Skip Header

Contribute Send feedback
Read comments (?) or add your own

P15205 (MAP1B_RAT) Reviewed, UniProtKB/Swiss-Prot

Last modified May 1, 2013. Version 109. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (1) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Microtubule-associated protein 1B

Short name=MAP-1B
Alternative name(s):
Neuraxin

Cleaved into the following 2 chains:

  1. MAP1B heavy chain
  2. MAP1 light chain LC1
Gene names
Name:Map1b
OrganismRattus norvegicus (Rat) [Reference proteome]
Taxonomic identifier10116 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeRattus

Protein attributes

Sequence length2459 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Phosphorylated MAP1B may play a role in the cytoskeletal changes that accompany neurite extension. Possibly MAP1B Binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing. Facilitates tyrosination of alpha-tubulin in neuronal microtubules. Required for synaptic maturation By similarity.

Subunit structure

3 different light chains, LC1, LC2 and LC3, can associate with MAP1A and MAP1B proteins. LC1 interacts with the amino-terminal region of MAP1B. Interacts with ANP32A and TIAM2. Interacts (via C-terminus) with GAN (via Kelch domains) By similarity. Interacts (via N-terminus) with DAPK1 By similarity. Interacts with the tubulin tyrosine TTL By similarity.

Subcellular location

Cytoplasmcytoskeleton Probable. Cytoplasm By similarity. Cell junctionsynapse By similarity. Cell projectiondendritic spine By similarity. Note: Colocalizes with DAPK1 in the microtubules and cortical actin fibers By similarity.

Tissue specificity

Nervous system (spinal cord, brain stem, cerebellum and cerebrum). Not expressed in liver, spleen, kidney, heart or muscle. Ref.3

Developmental stage

In cerebral cortex, spinal cord and sciatic nerve levels are high early in development but decrease during postnatal development and are low in adults. In dorsal root ganglia levels remain high throughout development. Ref.4

Induction

By nerve growth factor. Ref.2

Domain

Has a highly basic region with many copies of the sequence KKEE and KKEI/V, repeated but not at fixed intervals, which is responsible for the binding of MAP1B to microtubules. Ref.2

Post-translational modification

LC1 is coexpressed with MAP1B. It is a polypeptide generated from MAP1B by proteolytic processing. It is free to associate with both MAP1A and MAP1B. It interacts with the N-terminal region of MAP1B By similarity.

S-nitrosylation at Cys-2455 enhances interaction with microtubules, and may act as an effector modification for neuronal nitric oxide synthase control of growth-cone size, growth-cone collapse and axon retraction By similarity.

Sequence similarities

Belongs to the MAP1 family.

Caution

A C-terminal fragment of this protein (residues 1597 to 2459) was originally described as neuraxin in Ref.3.

Ontologies

Keywords
   Cellular componentCell junction
Cell projection
Cytoplasm
Cytoskeleton
Microtubule
Synapse
   DomainRepeat
   PTMAcetylation
Phosphoprotein
S-nitrosylation
   Technical termComplete proteome
Reference proteome
Gene Ontology (GO)
   Biological_processcellular response to growth factor stimulus

Inferred from expression pattern PubMed 9473667. Source: RGD

cellular response to peptide hormone stimulus

Inferred from expression pattern PubMed 9473667. Source: RGD

central nervous system development

Inferred from expression pattern PubMed 7838378. Source: RGD

developmental maturation

Inferred from expression pattern PubMed 12002439. Source: RGD

embryo development

Inferred from expression pattern PubMed 7838378. Source: RGD

induction of synaptic plasticity by chemical substance

Inferred from expression pattern PubMed 15374099. Source: RGD

microtubule bundle formation

Inferred from direct assay PubMed 11896150. Source: RGD

negative regulation of microtubule depolymerization

Inferred from direct assay PubMed 11896150. Source: RGD

peripheral nervous system axon regeneration

Inferred from expression pattern PubMed 10924960. Source: RGD

positive regulation of axon extension

Inferred from mutant phenotype PubMed 8838670. Source: RGD

positive regulation of microtubule polymerization

Inferred from direct assay PubMed 11896150. Source: RGD

positive regulation of neuron differentiation

Inferred from mutant phenotype PubMed 8450955. Source: RGD

response to carbohydrate stimulus

Inferred from expression pattern PubMed 16219303PubMed 8592116. Source: RGD

response to drug

Inferred from expression pattern PubMed 12598335PubMed 3252178. Source: RGD

response to estradiol stimulus

Inferred from expression pattern PubMed 14572470. Source: RGD

response to inorganic substance

Inferred from expression pattern PubMed 12410592. Source: RGD

response to insecticide

Inferred from expression pattern PubMed 18417317. Source: RGD

response to mechanical stimulus

Inferred from expression pattern PubMed 10906717. Source: RGD

response to vitamin A

Inferred from expression pattern PubMed 12414111. Source: RGD

synapse assembly

Inferred from expression pattern PubMed 17151949. Source: RGD

   Cellular_componentaxon

Inferred from direct assay PubMed 7908909. Source: RGD

cell junction

Inferred from electronic annotation. Source: UniProtKB-KW

growth cone

Inferred from direct assay PubMed 17870250. Source: RGD

microtubule

Inferred from electronic annotation. Source: UniProtKB-KW

microtubule associated complex

Inferred from direct assay PubMed 11896150PubMed 7908909. Source: RGD

perikaryon

Inferred from direct assay PubMed 14964776. Source: RGD

perinuclear region of cytoplasm

Inferred from direct assay PubMed 12410592. Source: RGD

plasma membrane

Inferred from direct assay PubMed 17151949. Source: RGD

postsynaptic density

Inferred from direct assay PubMed 14964776. Source: RGD

   Molecular_functionactin binding

Inferred from direct assay PubMed 11896150. Source: RGD

microtubule binding

Inferred from mutant phenotype PubMed 11896150. Source: RGD

phospholipid binding

Inferred from physical interaction PubMed 9278459. Source: RGD

protein complex binding

Inferred from direct assay PubMed 2470876. Source: RGD

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed By similarity
Chain2 – 24592458Microtubule-associated protein 1B
PRO_0000018608
Chain2 – 21972196MAP1B heavy chain
PRO_0000418381
Chain2198 – 2459262MAP1 light chain LC1
PRO_0000018609

Regions

Repeat1869 – 188517MAP1B 1
Repeat1886 – 190217MAP1B 2
Repeat1903 – 191917MAP1B 3
Repeat1920 – 193617MAP1B 4
Repeat1937 – 195317MAP1B 5
Repeat1954 – 197017MAP1B 6
Repeat1988 – 200417MAP1B 7
Repeat2005 – 202117MAP1B 8
Repeat2022 – 203817MAP1B 9
Repeat2039 – 205517MAP1B 10
Compositional bias559 – 1035477Glu-rich
Compositional bias588 – 786199Lys-rich (highly basic, contains many KKEE and KKEI/V repeats)
Compositional bias2224 – 231289Lys-rich

Amino acid modifications

Modified residue21N-acetylalanine By similarity
Modified residue3351Phosphoserine By similarity
Modified residue5261Phosphothreonine By similarity
Modified residue5401Phosphoserine By similarity
Modified residue5431Phosphoserine By similarity
Modified residue5601Phosphoserine By similarity
Modified residue6131Phosphoserine By similarity
Modified residue8201Phosphoserine By similarity
Modified residue8231Phosphoserine By similarity
Modified residue8241Phosphoserine By similarity
Modified residue9291Phosphoserine By similarity
Modified residue9841Phosphoserine By similarity
Modified residue9871Phosphoserine By similarity
Modified residue10081Phosphoserine By similarity
Modified residue11471Phosphoserine By similarity
Modified residue11491Phosphoserine By similarity
Modified residue12001Phosphoserine By similarity
Modified residue12431Phosphoserine By similarity
Modified residue12471Phosphoserine By similarity
Modified residue12511Phosphoserine Ref.5
Modified residue12561Phosphoserine Ref.5
Modified residue12671Phosphoserine By similarity
Modified residue12711Phosphoserine By similarity
Modified residue12731Phosphothreonine By similarity
Modified residue13041Phosphoserine By similarity
Modified residue13141Phosphoserine By similarity
Modified residue13161Phosphoserine By similarity
Modified residue13281Phosphotyrosine By similarity
Modified residue13291Phosphotyrosine By similarity
Modified residue13311Phosphoserine By similarity
Modified residue13681Phosphoserine By similarity
Modified residue13701Phosphoserine By similarity
Modified residue13791Phosphoserine By similarity
Modified residue13811Phosphoserine By similarity
Modified residue13881Phosphoserine By similarity
Modified residue13921Phosphoserine By similarity
Modified residue14001Phosphoserine By similarity
Modified residue14191Phosphoserine By similarity
Modified residue14351Phosphoserine By similarity
Modified residue14931Phosphoserine Ref.5
Modified residue16091Phosphoserine By similarity
Modified residue16111Phosphoserine By similarity
Modified residue16161Phosphoserine By similarity
Modified residue16441Phosphoserine By similarity
Modified residue17631Phosphoserine By similarity
Modified residue17701Phosphoserine By similarity
Modified residue17731Phosphoserine By similarity
Modified residue17761Phosphoserine By similarity
Modified residue17791Phosphothreonine By similarity
Modified residue17841Phosphoserine By similarity
Modified residue17871Phosphotyrosine By similarity
Modified residue17881Phosphoserine By similarity
Modified residue18081Phosphoserine By similarity
Modified residue18101Phosphoserine By similarity
Modified residue18721Phosphoserine By similarity
Modified residue19061Phosphoserine Ref.5
Modified residue19231Phosphothreonine By similarity
Modified residue19401Phosphothreonine By similarity
Modified residue20251Phosphoserine By similarity
Modified residue20631Phosphoserine By similarity
Modified residue20891Phosphoserine By similarity
Modified residue22621Phosphoserine By similarity
Modified residue22801Phosphoserine By similarity
Modified residue24551S-nitrosocysteine By similarity

Experimental info

Sequence conflict1271M → V in AAB17068. Ref.1
Sequence conflict1401T → S Ref.1
Sequence conflict21121R → K in CAA34620. Ref.3
Sequence conflict21691L → I in CAA34620. Ref.3

Sequences

Sequence LengthMass (Da)Tools
P15205 [UniParc].

Last modified September 26, 2001. Version 2.
Checksum: 2E3F6872DEDB8BA2

FASTA2,459269,500
        10         20         30         40         50         60 
MATVVVEATE PEPSGSIGNP AATTSPSLSH RFLDSKFYLL VVVGETVTEE HLRRAIGNIE 

        70         80         90        100        110        120 
LGIRSWETNL IECNLDQELK LFVSRHSARF SPEVPGQKIL HHRSDVLETV VLINPSDEAV 

       130        140        150        160        170        180 
STEVRLMITD AARHKLLVLT GQCFENTGEL ILQSGSFSFQ NFIEIFTDQE IGELLSTTHP 

       190        200        210        220        230        240 
ANKASLTLFC PEEGDWKNSN LDRHNLQDFI NIKLNSASIL PEMEGLSEFT EYLSESVEVP 

       250        260        270        280        290        300 
SPFDILEPPT SGGFLKLSKP CCYIFPGGRG DSALFAVNGF NMLINGGSER KSCFWKLIRH 

       310        320        330        340        350        360 
LDRVDSILLT HIGDDNLPGI NSMLQRKIAE LEEESQGSTS NSDWMKNLIS PDLGVVFLNV 

       370        380        390        400        410        420 
PENLKNPEPN IKMKRSTEEA CFTLQYLNKL SMKPEPLFRS VGNAIEPVIL FQKMGVGKLK 

       430        440        450        460        470        480 
MYVLNPVKSS KEMQYFMQQW TGTNKDKAEL ILPNGQEVDI PISYLASVSS LIVWHPANPA 

       490        500        510        520        530        540 
EKIIRVLFPG NSTQYNILEG LEKLKHLDFL KQPLATQKDL TGQVSTPPVK QVKLKQRADS 

       550        560        570        580        590        600 
RESLKPATKP LSSKSVRKES KEEAPEATKA SQVEKTPKVE SKEKVIVKKD KPGKVESKPS 

       610        620        630        640        650        660 
VTEKEVPSKE EQSPVKAEVA EKAATESKPK VTKDKVVKKE IKTKPEEKKE EKPKKEVAKK 

       670        680        690        700        710        720 
EDKTPLKKDE KPKKEEAKKE IKKEIKKEEK KELKKEVKKE TPLKDAKKEV KKDEKKEVKK 

       730        740        750        760        770        780 
EEKEPKKEIK KISKDIKKST PLSDTKKPAA LKPKVAKKEE PTKKEPIAAG KLKDKGKVKV 

       790        800        810        820        830        840 
IKKEGKTTEA AATAVGTAAV AAAAGVAASG PAKELEAERS LMSSPEDLTK DFEELKAEEI 

       850        860        870        880        890        900 
DVAKDIKPQL ELIEDEEKLK ETEPGEAYVI QKETEVSKGS AESPDEGITT TEGEGECEQT 

       910        920        930        940        950        960 
PEELEPVEKQ GVDDIEKFED EGAGFEESSE AGDYEEKAET EEAEEPEEDG EDNVSGSASK 

       970        980        990       1000       1010       1020 
HSPTEDEEIA KAEADVHIKE KRESVASGDD RAEEDMDEAL EKGEAEQSEE EGEEEEDKAE 

      1030       1040       1050       1060       1070       1080 
DAREEDHEPD KTEAEDYVMA VVDKAAEAGV TEDQYDFLGT PAKQPGVQSP SREPASSIHD 

      1090       1100       1110       1120       1130       1140 
ETLPGGSESE ATASDEENRE DQPEEFTATS GYTQSTIEIS SEPTPMDEMS TPRDVMTDET 

      1150       1160       1170       1180       1190       1200 
NNEETESPSQ EFVNITKYES SLYSQEYSKP VVASFNGLSD GSKTDATDGR DYNASASTIS 

      1210       1220       1230       1240       1250       1260 
PPSSMEEDKF SKSALRDAYR PEETDVKTGA ELDIKDVSDE RLSPAKSPSL SPSPPSPIEK 

      1270       1280       1290       1300       1310       1320 
TPLGERSVNF SLTPNEIKAS AEGEATAVVS PGVTQAVVEE HCASPEEKTL EVVSPSQSVT 

      1330       1340       1350       1360       1370       1380 
GSAGHTPYYQ SPTDEKSSHL PTEVTENAQA VPVSFEFTEA KDENERSSIS PMDEPVPDSE 

      1390       1400       1410       1420       1430       1440 
SPIEKVLSPL RSPPLIGSES AYEDFLSADD KALGRRSESP FEGKNGKQGF SDKESPVSDL 

      1450       1460       1470       1480       1490       1500 
TSDLYQDKQE EKRAGFIPIK EDFSPEKKAS DAEIMSSQSA LALDERKLGG DGSPTQVDVS 

      1510       1520       1530       1540       1550       1560 
QFGSFKEDTK MSISEGTVSD KSATPVDEGA EDTYSHMEGV ASVSTASVAT SSFPEPTTDD 

      1570       1580       1590       1600       1610       1620 
VSPSLHAEVG SPHSTEVDDS LSVSVVQTPT TFQETEMSPS KEECPRPMSI SPPDFSPKTA 

      1630       1640       1650       1660       1670       1680 
KSRTPVQDHR SEQSSMSIEF GQESPEHSLA MDFSRQSPDH PTVGAGMLHI TENGPTEVDY 

      1690       1700       1710       1720       1730       1740 
SPSDIQDSSL SHKIPPTEEP SYTQDNDLSE LISVSQVEAS PSTSSAHTPS QIASPLQEDT 

      1750       1760       1770       1780       1790       1800 
LSDVVPPRDM SLYASLASEK VQSLEGEKLS PKSDISPLTP RESSPTYSPG FSDSTSGAKE 

      1810       1820       1830       1840       1850       1860 
STAAYQTSSS PPIDAAAAEP YGFRSSMLFD TMQHHLALSR DLTTSSVEKD NGGKTPGDFN 

      1870       1880       1890       1900       1910       1920 
YAYQKPESTT ESPDEEDYDY ESHEKTIQAH DVGGYYYEKT ERTIKSPCDS GYSYETIEKT 

      1930       1940       1950       1960       1970       1980 
TKTPEDGGYS CEITEKTTRT PEEGGYSYEI SEKTTRTPEV SGYTYEKTER SRRLLDDISN 

      1990       2000       2010       2020       2030       2040 
GYDDTEDGGH TLGDCSYSYE TTEKITSFPE SESYSYETTT KTTRSPDTSA YCYETMEKIT 

      2050       2060       2070       2080       2090       2100 
KTPQASTYSY ETSDRCYTPE RKSPSEARQD VDLCLVSSCE FKHPKTELSP SFINPNPLEW 

      2110       2120       2130       2140       2150       2160 
FAGEEPTEES ERPLTQSGGA PPPSGGKQQG RQCDETPPTS VSESAPSQTD SDVPPETEEC 

      2170       2180       2190       2200       2210       2220 
PSITADANLD SEDESETIPT DKTVTYKHMD PPPAPMQDRS PSPRHPDVSM VDPEALAIEQ 

      2230       2240       2250       2260       2270       2280 
NLGKALKKDL KEKAKTKKPG TKTKSSSPVK KGDGKSKPSA ASPKPGALKE SSDKVSRVAS 

      2290       2300       2310       2320       2330       2340 
PKKKESVEKA MKTTTTPEVK ATRGEEKDKE TKNAANASAS KSVKTATAGP GTTKTAKSST 

      2350       2360       2370       2380       2390       2400 
VPPGLPVYLD LCYIPNHSNS KNVDVEFFKR VRSSYYVVSG NDPAAEEPSR AVLDALLEGK 

      2410       2420       2430       2440       2450 
AQWGSNMQVT LIPTHDSEVM REWYQETHEK QQDLNIMVLA SSSTVVMQDE SFPACKIEL 

« Hide

References

« Hide 'large scale' references
[1]"Isolation and sequencing of the 5' end of the rat microtubule-associated protein (MAP1B)-encoding cDNA."
Liu D., Fischer I.
Gene 171:307-308(1996) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-142.
Strain: Sprague-Dawley.
Tissue: Testis.
[2]"Identification of two distinct microtubule binding domains on recombinant rat MAP 1B."
Zauner W., Kratz J., Staunton J., Feick P., Wiche G.
Eur. J. Cell Biol. 57:66-74(1992) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 96-2459, DOMAIN, INDUCTION.
Strain: Sprague-Dawley.
Tissue: Brain and Glial tumor.
[3]"Neuraxin, a novel putative structural protein of the rat central nervous system that is immunologically related to microtubule-associated protein 5."
Rienitz A., Grenningloh G., Hermans-Borgmeyer I., Kirsch J., Littauer U.Z., Prior P., Gundelfinger E.D., Schmitt B., Betz H.
EMBO J. 8:2879-2888(1989) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1541-2459, TISSUE SPECIFICITY.
Tissue: Spinal cord.
[4]"Differential regulation of microtubule-associated protein 1B (MAP1B) in rat CNS and PNS during development."
Ma D., Nothias F., Boyne L.J., Fischer I.
J. Neurosci. Res. 49:319-332(1997) [PubMed] [Europe PMC] [Abstract]
Cited for: DEVELOPMENTAL STAGE, PHOSPHORYLATION.
[5]"Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites."
Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.
Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006) [PubMed] [Europe PMC] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1251; SER-1256; SER-1493 AND SER-1906, MASS SPECTROMETRY.
Tissue: Renal collecting duct.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
U52950 mRNA. Translation: AAB17068.1.
X60370 mRNA. Translation: CAC16162.1.
X16623 mRNA. Translation: CAA34620.1. Sequence problems.
IPIIPI00372009.
PIRA56577.
RefSeqNP_062090.1. NM_019217.1.
UniGeneRn.220177.
Rn.98152.

3D structure databases

ProteinModelPortalP15205.
ModBaseSearch...

Protein-protein interaction databases

IntActP15205. 1 interaction.

PTM databases

PhosphoSiteP15205.

Proteomic databases

PaxDbP15205.
PRIDEP15205.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

GeneID29456.
KEGGrno:29456.
UCSCRGD:3043. rat.

Organism-specific databases

CTD4131.
RGD3043. Map1b.

Phylogenomic databases

eggNOGNOG12793.
HOGENOMHOG000063256.
HOVERGENHBG052409.
InParanoidP15205.
KOK10429.
OrthoDBEOG44XJFW.

Gene expression databases

ArrayExpressP15205.
GenevestigatorP15205.
GermOnlineENSRNOG00000017428. Rattus norvegicus.

Family and domain databases

InterProIPR026074. MAP1.
IPR027321. MAP1B.
IPR000102. MAP1B_neuraxin.
[Graphical view]
PANTHERPTHR13843. PTHR13843. 1 hit.
PTHR13843:SF5. PTHR13843:SF5. 1 hit.
PfamPF00414. MAP1B_neuraxin. 6 hits.
[Graphical view]
PROSITEPS00230. MAP1B_NEURAXIN. 8 hits.
[Graphical view]
ProtoNetSearch...

Other

NextBio609232.

Entry information

Entry nameMAP1B_RAT
AccessionPrimary (citable) accession number: P15205
Secondary accession number(s): Q62958, Q9ER21, Q9QW92
Entry history
Integrated into UniProtKB/Swiss-Prot: April 1, 1990
Last sequence update: September 26, 2001
Last modified: May 1, 2013
This is version 109 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Relevant documents

SIMILARITY comments

Index of protein domains and families